Germany· DE-A57-4b0c0d788e0967a7
Neokay
A phytomenadione product containing phytomenadione, registered in Germany by Neoceuticals Limited. The same ATC class is registered in 15 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Phytomenadione is registered in 15 of 19 countries.
Countries holding a registration under ATC B02BA01 (phytomenadione), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 8 of them publish a price we can compare per daily dose
Phytomenadione · ATC B02BA01
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Phytomenadione
- Manufacturer
- Neoceuticals Limited
- Country
- Germany (DE)
- ATC code
- B02BA01
- ATC class
- Phytomenadione
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
188 interactions on record for phytomenadione.
Graded by severity as the source publishes them — 6 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Phytomenadione · interactions on record
188 records
- 6 moderate
- 2 minor
- 180 info
Most severe, free to view
- DicoumarolB01AA01moderate
- WarfarinB01AA03moderate
- ColestyramineC10AC01moderate
- ColestipolC10AC02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Phytomenadione in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesphytonadioneAmneal Pharmaceuticals LLC
- United KingdomAmPhytom 10mg tabletsEssential-Healthcare Ltd
- FinlandK1 Keyvit
- NorwayKA-VitInfectopharm
- SpainKONAKION 10 mg/ml SOLUCION ORAL/SOLUCION INYECTABLECheplapharm Arzneimittel Gmbh
- CanadaHEMOPHYTDOMES PHARMA
- CzechiaKANAVITZentiva, k.s., Praha
- BelgiumKonakion 10 mg/1 mlCheplapharm Arzneimittel
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Konakion
- Belgium · Konakion, Konakion Paediatric
- Cyprus · Kanavit
- Czechia · Kanavit
- Denmark · Konakion Novum, Menadion Scanpharm
- Spain · Konakion, Konakion Pediátrico
- Finland · Konakion Novum
- France · Vitamine K1 Cheplapharm, Vitamine K1 Nourrissons Cheplapharm
- United Kingdom (Northern Ireland) · Konakion Mm Ampoules, Konakion Mm Paediatric
- Croatia · Konakion Mm
- Hungary · Konakion
- Ireland · Konakion Mm Ampoules, Konakion Mm Paediatric Ampoules
- Italy · Konakion, Konakion Prima Infanzia
- Malta · Konakion Mm Ampoules, Konakion Mm Paediatric Ampoules
- Netherlands · Konakion Mixed Micelles, Konakion Mm Voor Kinderen
- Norway · Konakion
- Poland · Phytomenadione Bb Pharma, Vitacon
- Portugal · Kanakion Mm, Kanakion Mm Pediátrico
- Romania · Fitomenadion Terapia
- Sweden · Konakion
- Slovakia · Kanavit
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3a6c23cd-5099-4e1b-8067-3f8a295140fa GET /v1/drugs/3a6c23cd-5099-4e1b-8067-3f8a295140fa?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Phytomenadione",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about phytomenadione.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.